Default company background
BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. in United States

15 jobs at BridgeBio Pharma, Inc. in United States


  • BridgeBio Pharma, Inc. San Francisco, United States

    About BridgeBio · BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genet ...


  • BridgeBio Pharma, Inc. San Francisco, United States

    About BridgeBio · BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genet ...


  • BridgeBio Pharma, Inc. San Francisco, United States

    About BridgeBio · BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genet ...

  • BridgeBio Pharma, Inc.

    Executive Assistant

    1 week ago


    BridgeBio Pharma, Inc. San Francisco, United States

    About Calcilytix & BridgeBio Pharma · Calcilytix Therapeutics, an affiliate of BridgeBio Pharma, is developing encaleret (CLTX-305), a negative allosteric modulator of the calcium-sensing receptor (CaSR) for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), a geneti ...


  • BridgeBio Pharma, Inc. San Francisco, United States

    About Eidos Therapeutics & BridgeBio Pharma · Eidos Therapeutics, an affiliate of BridgeBio Pharma, is a Phase 3 developmental-stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. ...

  • BridgeBio Pharma, Inc.

    Research Associate

    1 week ago


    BridgeBio Pharma, Inc. San Francisco, United States

    About Eidos Therapeutics & BridgeBio Pharma · Eidos Therapeutics, an affiliate of BridgeBio Pharma, is a Phase 3 developmental-stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. ...


  • BridgeBio Pharma, Inc. San Francisco, CA, United States

    About Calcilytix & BridgeBio Pharma · Calcilytix Therapeutics, an affiliate of BridgeBio Pharma, is developing encaleret (CLTX-305), a negative allosteric modulator of the calcium-sensing receptor (CaSR) for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), a genet ...


  • BridgeBio Pharma, Inc. San Francisco, United States

    About BridgeBio · BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genet ...


  • BridgeBio Pharma, Inc. San Francisco, United States

    About Calcilytix & BridgeBio Pharma · Calcilytix Therapeutics, an affiliate of BridgeBio Pharma, is developing encaleret (CLTX-305), a negative allosteric modulator of the calcium-sensing receptor (CaSR) for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), a geneti ...


  • BridgeBio Pharma, Inc. San Francisco, CA, United States

    BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in acad ...


  • BridgeBio Pharma, Inc. San Francisco, CA, United States

    About Calcilytix & BridgeBio Pharma · Calcilytix Therapeutics, an affiliate of BridgeBio Pharma, is developing encaleret (CLTX-305), a negative allosteric modulator of the calcium-sensing receptor (CaSR) for the treatment of Autosomal Dominant Hypocalcemia Type 1 (ADH1), a genet ...


  • BridgeBio Pharma, Inc. San Francisco, United States

    About BridgeBio · BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genet ...


  • BridgeBio Pharma, Inc. San Francisco, United States

    About MLBio Solutions & BridgeBio Pharma · ML Bio Solutions (ML Bio), a BridgeBio company, is a biotechnology company founded in 2018, yet the company's founders have been dedicated to finding a cure for Limb girdle muscular dystrophy type 2I/R9 FKRP-related (LGMD2I/LGMDR9) for c ...


  • BridgeBio Pharma, Inc. San Francisco, CA, United States

    About BridgeBio BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in geneti ...


  • BridgeBio Pharma, Inc. San Francisco, CA, United States

    About BridgeBio · BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in gene ...